FLUOROPASSIV - Trademark Details
Status: 700 - Registered
Serial Number
79189100
Registration Number
5135131
Word Mark
FLUOROPASSIV
Status
700 - Registered
Status Date
2017-02-07
Filing Date
2016-03-31
Registration Number
5135131
Registration Date
2017-02-07
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2016-11-22
Attorney Name
Law Office Assigned Location Code
N60
Employee Name
VAGHANI, MAYUR C
Statements
Goods and Services
Surgical apparatus and instruments; medical apparatus and instruments for use in cardiovascular procedures; prosthetic vascular grafts; prosthetic endovascular grafts; stents, vascular prostheses; vascular prostheses with flared outflow; vascular prostheses with customisable outflow; prosthetic vascular woven grafts; prosthetic endovascular knitted grafts; expanded polytetrafluoroethylene (ePTFE) vascular grafts; surgical implants comprising prosthetic materials; suture materials; patches for repair and reconstruction of internal tissue, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; implantable medical systems, namely, cardiac valves for surgical prostheses, stents, prosthetic vascular grafts, vascular prostheses, prosthetic vascular grafts, prosthetic endovascular grafts, and catheters; implantable medical devices, namely, implants consisting of prosthetic materials, synthetic vascular prostheses, prosthetic vascular grafts, and synthetic heart valve conduits; prosthetic vascular grafts; prosthetic endovascular grafts; surgical graft materials, namely, prosthetic vascular grafts, and vascular prostheses for the treatment of aneurysmal or occlusive arterial disease; medical devices for use in endovascular procedures, namely, medical devices for use in treating cardiovascular disease; synthetic thoracic stents; synthetic thoracic stent grafts; synthetic stent grafts; synthetic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems comprising more than one component comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems comprising components of more than one stent graft comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems comprising components of more than one type of stent graft comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; thoracic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; prosthetic systemic vascular grafts; prosthetic vascular straight grafts; prosthetic vascular abdominal grafts; prosthetic vascular thoracic grafts; prosthetic vascular branched grafts; prosthetic vascular pre-curved grafts; prosthetic vascular aortic arch grafts; prosthetic vascular branched arch grafts; delivery systems for synthetic stent graft systems comprised of medical instruments for intraluminal emplacement of stents or of synthetic stent grafts, namely, stent or synthetic stent graft delivery systems; aneurysm repair systems comprised of catheter delivered stent grafts, medical instruments for intraluminal emplacement of stents or stent systems or of synthetic stent grafts, namely, stent delivery systems or stent graft delivery systems or synthetic stent graft delivery systems; medical devices, namely, aneurysm repair devices; cardiac valves for surgical prostheses; cardiac valve replacement systems, namely, prosthetic cardiac valves; heart valves, namely, prosthetic heart valves; heart valve conduits, namely, catheters for implanting heart valves; cardiac patches, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; vascular patches, namely, cardiovascular patches, pericardial patches, and carotid patches, surgical mesh comprised primarily of prosthetic materials; thin wall cardiovascular patches, namely, surgical mesh comprised primarily of prosthetic materials; thin wall carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; fluoropolymer cardiovascular patches, namely, surgical mesh comprised primarily of prosthetic materials; fluoropolymer carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; knitted cardiovascular patches, namely, surgical mesh comprised primarily of prosthetic materials; knitted carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; gelatin sealed cardiovascular patches, namely, surgical mesh comprised primarily of prosthetic materials; gelatin sealed carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; parts and fittings for all of the aforementioned goods
Translation of Words in Mark
The wording "FLUOROPASSIV" has no meaning.
Classification Information
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2016-07-15
Primary Code
010
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (A Private Limited Company).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (A Private Limited Company).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (A Private Limited Company).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (A Private Limited Company).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
JEFFREY H. GREGER
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1302943
International Registration Date
2016-03-31
International Publication Date
2016-07-14
International Renewal Date
2026-03-31
Auto Protection Date
2018-01-14
International Status
001 - Request for extension of protection established
International Status Date
2016-07-14
Priority Claimed In
True
Priority Claimed Date
2015-10-16
First Refusal In
True
Trademark Events
Event Date | Event Description |
2016-07-14 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2016-07-15 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2016-07-15 | ASSIGNED TO EXAMINER |
2016-07-19 | APPLICATION FILING RECEIPT MAILED |
2016-07-19 | NON-FINAL ACTION WRITTEN |
2016-07-20 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2016-07-20 | REFUSAL PROCESSED BY MPU |
2016-07-20 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2016-08-05 | REFUSAL PROCESSED BY IB |
2016-09-08 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2016-09-08 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2016-09-17 | ASSIGNED TO LIE |
2016-09-22 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2016-09-22 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2016-10-13 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2016-10-17 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2016-11-02 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2016-11-22 | PUBLISHED FOR OPPOSITION |
2016-11-22 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2017-02-07 | REGISTERED-PRINCIPAL REGISTER |
2017-05-07 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
2017-06-03 | FINAL DISPOSITION PROCESSED |
2017-06-03 | FINAL DISPOSITION NOTICE SENT TO IB |
2017-06-24 | FINAL DECISION TRANSACTION PROCESSED BY IB |
2022-02-07 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |